Treace Medical Concepts, Inc. (TMCI)
1.45
+0.04
(+2.84%)
USD |
NASDAQ |
Apr 02, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 20:00
Treace Medical Concepts EPS Diluted (Quarterly) : -0.1471 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UFP Technologies, Inc. | 2.250 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.394M |
| Revenue (Quarterly) | 62.52M |
| Total Expenses (Quarterly) | 71.91M |
| Enterprise Value | 117.15M |
| Gross Profit Margin (Quarterly) | 80.62% |
| Profit Margin (Quarterly) | -15.03% |
| Earnings Yield | -62.19% |
| Normalized Earnings Yield | -60.20 |